Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of GSK Biologicals' Boostrix® Vaccine When Compared With Decavac™ in Adults Aged 65 Years or Older.

NCT00835237 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00835237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00835237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of GSK Biologicals' Boostrix® Vaccine When Compared With Decavac™ in Adults Aged 65 Years or Older.
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
February 17, 2009
Completion date
October 15, 2009
Enrollment
1,332 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

acellular pertussis, diphtheria, diphtheria-tetanus-acellular pertussis vaccines, tetanus